section name header

Basics

Description
Epidemiology

Incidence

  • There are ~800,000 percutaneous injuries per year in the US. Most needlesticks occur in the OR from suture needlesticks.
  • HIV seroconversion after a needle stick from an HIV positive patient is 0.3%; in 2004, 57 healthcare workers reported contracting HIV in the workplace.
  • Hepatitis B seroconversion after parenteral exposure can vary between 2% and 40% for the nonimmunized. Since the introduction of the hepatitis B vaccination, infections have decreased from 10,721 in 1983 to 384 in 1999 (a 96% reduction).
  • Hepatitis C seroconversion after parenteral exposure is estimated at 1.3%.
  • Tuberculosis infection among all healthcare workers has an incidence ranging from 3.6 to 5.4 workers per 100,000 from 1994 to 2000.
  • HPV infection following inhalational exposure is unknown; most likely very rare.

Morbidity/Mortality

  • HIV infects ~5 million people worldwide annually. Roughly 900,000 cases of AIDS were reported in the US in 2002. With appropriate antiretroviral therapy early in the disease course, HIV patients have a life expectancy between 20 and 50 years. Without treatment, however, the median life expectancy is estimated to be between 9 and 11 years from the time of infection. The major cause of death is opportunistic infections in the later stages of the disease.
  • Hepatitis B causes asymptomatic disease in 60–65% of infected people, acute hepatitis in 20–25% of infected people, and chronic hepatitis in roughly 1% of people.
  • Hepatitis C causes active liver disease in 75–80% of infected people, cirrhosis in 10–20% of infected people, and liver cancer in 1–5% of cirrhosis patients.
  • New, active tuberculosis infections affect 16,000 people per year in the US. forty-five percent of these infections occur in immigrants. In 10–50% of immunocompromised hosts, the bacteria migrate to various organs and cause a disseminated disease. The major cause of death is due to lung disease.
  • Laryngeal papillomatosis does not cause a malignant disease, but frequently causes recurrent papillomas that require multiple operations for treatment.
  • Creutzfeldt–Jakob disease affects ~1 in 1,000,000 people each year. It is uniformly fatal and has an average duration of 7 months.
Etiology/Risk Factors
Physiology/Pathophysiology
Prevantative Measures

Diagnosis

Differential Diagnosis

Will vary depending on the specific infectious agent.

Treatment

Follow-Up

Determined by the disease in question

References

  1. Belay ED. Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol. 1999;53:283314.
  2. Centers for Disease Control and Prevention . Novel influenza A infections among healthcare personnel – United States, April-May 2009. 2009;58(23):641645.
  3. Garden JM , O’Banion MK , Shelnitz LS , et al. Papillomavirus in the vapor of carbon dioxide laser-treated verrucae. JAMA. 1988;259(8):11991202.
  4. Centers for Disease Control and Prevention . Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. 2001;50(RR11):142.
  5. Fine A. New York State Department of Health. Summary of biological warfare agents. 2001.
  6. Texas Department of State Health Services . Texas contaminated sharps injuries, 2008. Available at: http://www.dshs.state.tx.us/idcu/health/infection_control/bloodborne_pathogens/report/2008/sharps2008.pdf (accessed February 15, 2011.

Additional Reading

See Also (Topic, Algorithm, Electronic Media Element)

Codes

ICD9

V01.9 Contact with or exposure to unspecified communicable disease

ICD10

Z20.9 Contact w and exposure to unsp communicable disease

Clinical Pearls

Author(s)

Russell K. McAllister , MD

andrew L. Barker , MD